Back to search
Migraine Without Aura
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Migraine Without Aura trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Migraine Without Aura trials you may qualify forThe purpose of this study is to test the long-term safety of rimegepant in the acute treatment of migraine in children and adolescents (≥ 6 to \< 18 years of ag…
The purpose of this study is to test the safety and efficacy of BHV-3000 versus placebo in the acute treatment of moderate or severe migraine in children and ad…
The goal of this randomized clinical trial is to evaluate two different non-drug, virtual treatment options designed to improve the lives of patients with migra…
The study aims to test interactions between drug and placebo-responses in acute migraine treatment and to assess variation in adverse events according to treatm…
The study aims to test interactions between drug and placebo-responses in acute migraine treatment and to assess variation in adverse events according to treatm…
This study uses a factorial research design to evaluate a nurse delivered mind body intervention using different doses of 3 treatment components to determine th…
The purpose of this study is to evaluate safety and effectiveness of NURTEC® ODT 75 mg (Rimegepant sulfate) in adult patients with acute treatment of migraine w…
The aim is to compare the effectiveness of a behavioral treatment, the Acceptance and Commitment Therapy, provided as an add-on to the prophylactic treatment (t…
This is a prospective, double-blind, sham-controlled, randomized, decentralized trial. This study aims to assess the safety and efficacy of the Mi-Helper transn…